Belite Bio, Inc (BLTE) Non Operating Income (2022 - 2026)

Belite Bio (BLTE) has reported Non Operating Income for 5 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income rose 363.39% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.4 billion (up 57.9% YoY), while the FY2025 annual figure was $6.6 million, up 71.0% from the prior year.
• Non Operating Income came in at $5.7 million for Q1 2026 at Belite Bio, down from $2.8 billion in the prior quarter.
• The five-year high for Non Operating Income was $2.8 billion in Q4 2025, with the low at -$8.0 million in Q1 2023.
• Average Non Operating Income over 5 years is $595.5 million, with a median of $126.0 million recorded in 2022.
• Across the five-year window, Non Operating Income sank 99.98% in 2023 and jumped 3929529.63% in 2024, its largest moves.
• Year by year, Non Operating Income stood at -$62000.0 in 2022, then surged by 41.94% to -$36000.0 in 2023, then jumped by 3769544.44% to $1.4 billion in 2024, then soared by 102.87% to $2.8 billion in 2025, then tumbled by 99.79% to $5.7 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $5.7 million, $2.8 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.